Hi Guest Login
Home > Tests > bcr-abl test > Noida
₹8510 ₹6808
Report Time
Report by Tue/Thur/Sat by 7 pmFREE
Home Sample Collection
Age Group
All Age Group
Parameters Included
1
Recomended for
Both
Fasting
No Fasting Required
Report Time
Report by Tue/Thur/Sat by 7 pm
Exclusive Offer
₹6808
₹8510
FREE Home Sample Collection*
FREE Smart Report
Get a callback from our Health advisor.
Understanding the Test
Test Measures
City Price Info
The BCR-ABL Quantitative Real-Time PCR Test is an advanced molecular diagnostic tool used to detect and precisely measure the BCR-ABL gene fusion, a genetic abnormality central to the diagnosis and management of Chronic Myeloid Leukemia (CML). In Noida, accessing this critical test is made simple through convenient options like MAX@Home's home sample collection. By accurately quantifying BCR-ABL transcript levels, this high-sensitivity assay is essential for early diagnosis, assessing targeted therapy effectiveness, monitoring treatment response, and detecting minimal residual disease (MRD), enabling timely and personalized clinical decisions for patients in the region.
The BCR-ABL Quantitative Real-Time PCR Test accurately measures the amount of BCR-ABL gene transcripts in the blood, which is vital for assessing disease burden and tracking the progression of chronic myeloid leukemia (CML). Key measures include quantifying BCR-ABL transcript levels and expressing them on the International Scale (IS%), a standardized metric crucial for monitoring treatment response. For healthcare providers in Noida, timely and reliable results from this test are essential for evaluating molecular response levels and detecting minimal residual disease (MRD), ensuring effective, precision-guided patient management and treatment adjustment.
| Location | Price |
|---|---|
bcr-abl test Price in Dehradun |
8780 |
bcr-abl test Price in Gurgaon |
8510 |
bcr-abl test Price in Ghaziabad |
8510 |
bcr-abl test Price in Faridabad |
8510 |
bcr-abl test Price in Noida |
8510 |
bcr-abl test Price in Delhi |
8510 |
bcr-abl test Price in Lucknow |
7320 |
bcr-abl test Price in Greater Noida |
8510 |
The BCR-ABL quantitative real-time PCR test is a specialised molecular test used to detect and measure the BCR-ABL gene fusion in the blood. Detection of the BCR-ABL gene fusion is strongly associated with specific leukemias and should be interpreted alongside clinical findings and other investigations.
It helps assess disease presence, monitor treatment response, and track minimal residual disease at a molecular level.
The BCR-ABL Quantitative RT-PCR test near you plays a critical role in both the diagnosis and long-term management of certain types of leukemia, especially chronic myeloid leukemia (CML). It is a highly sensitive molecular test that helps doctors detect disease at an early stage and monitor how well treatment is working over time.
This test helps identify the presence of the BCR-ABL gene mutation, which is a key marker for certain leukemias. Early detection enables timely diagnosis and allows treatment to begin at the right stage, improving overall outcomes.
The test quantitatively measures BCR-ABL transcript levels in the blood, making it possible to track disease progression or remission. Regular monitoring helps in understanding whether the disease is stable, improving, or worsening.
It is widely used to evaluate how effectively targeted therapies, such as tyrosine kinase inhibitors (TKIs), are working. A decreasing BCR-ABL level usually indicates a positive response to treatment.
Based on the test results, doctors can make informed decisions about continuing, adjusting, or changing treatment plans. It helps in identifying resistance to therapy early and ensures timely intervention for better disease management.
The BCR-ABL Quantitative Real-Time PCR test is widely used in the diagnosis, monitoring, and management of specific blood cancers. It provides valuable molecular insights that help doctors make timely and accurate clinical decisions.
Chronic Myeloid Leukaemia (CML) is a type of blood cancer strongly associated with the presence of the BCR-ABL gene fusion (Philadelphia chromosome). This test is essential not only for confirming the diagnosis but also for long-term monitoring. It helps track how well the disease is responding to treatment and whether molecular remission is being achieved or maintained.
In certain cases of Acute Lymphoblastic Leukemia (ALL), patients may test positive for the BCR-ABL gene. Identifying this mutation is important because it directly influences treatment strategy, including the use of targeted therapies. The test helps in both diagnosis and ongoing monitoring of response.
The BCR-ABL PCR test is highly sensitive and can detect very low levels of cancer cells that may remain after treatment-known as minimal residual disease (MRD). Monitoring MRD is crucial for assessing the risk of relapse and ensuring that even microscopic disease is identified early.
Regular BCR-ABL testing is a key part of follow-up care for leukemia patients. It helps doctors evaluate treatment effectiveness, detect any early signs of disease recurrence, and make timely adjustments to therapy to maintain disease control and improve patient outcomes.
The BCR-ABL Quantitative Real-Time PCR test is recommended for individuals who show symptoms suggestive of blood disorders or those who require ongoing monitoring for leukaemia. Early testing can support timely diagnosis and better disease management.
Continuous fatigue, low energy levels, or unexplained weakness may be linked to underlying blood abnormalities. If these symptoms persist despite adequate rest, further evaluation through tests like BCR-ABL PCR may be advised.
Sudden, unintentional weight loss or recurring fever without a clear cause can be early warning signs of leukemia or other serious conditions. This test helps in identifying potential underlying causes.
A weakened immune system leading to frequent infections, or symptoms like easy bruising and bleeding, may indicate abnormalities in blood cell production. The test can help in assessing such conditions more accurately.
Individuals already diagnosed with leukemia require regular BCR-ABL PCR testing to monitor disease progression and evaluate how well the treatment is working over time.
People with abnormal blood test results, a history of blood disorders, or certain genetic risk factors may be advised to undergo this test as part of early screening and preventive care.
|
Paramerer |
Details |
|
Test Name |
BCR-ABL Quantitative Real-Time PCR |
|
Also Known As |
BCR-ABL PCR, CML PCR Test |
|
Sample Type |
Blood |
|
Gender |
Both |
|
Age Group |
All |
|
Fasting Required |
No |
|
Report Time |
24–48 Hours |
|
Home Collection |
Available |
The BCR-ABL quantitative real-time PCR test near you is designed to offer a seamless and hassle-free experience. From booking to report delivery, the entire process is managed with precision, ensuring accuracy, convenience, and timely results.
Schedule your test easily via website, app, or call/WhatsApp. Choose a convenient time slot and get instant confirmation.
A trained phlebotomist visits your home and collects a blood sample using sterile equipment while maintaining strict hygiene standards.
The sample is transported to NABL-accredited labs and analyzed using advanced real-time PCR technology for precise genetic detection.
Reports are reviewed by experts and delivered via WhatsApp, email, or app for quick access.
Proper preparation helps ensure accurate results and a smooth sample collection experience. While this test is simple and does not require extensive preparation, following a few basic guidelines can improve reliability and comfort.
Fasting is generally not required for the BCR-ABL PCR test. However, if your doctor has given specific instructions based on your condition, it’s important to follow them.
Always inform your doctor about any medications, ongoing treatments, or recent medical procedures-especially cancer therapies-as these can influence test results.
Certain vitamins or supplements may interfere with test outcomes. Avoid taking non-prescribed supplements before the test unless advised by your healthcare provider.
Scheduling the test in the morning can help maintain consistency in results, especially when monitoring levels over time.
Drinking adequate water before the test helps make blood collection easier and more comfortable.
Several factors can influence the accuracy and interpretation of the BCR-ABL Quantitative Real-Time PCR test. Understanding these variables is important for ensuring reliable results and effective disease monitoring over time.
Certain cancer treatments, especially targeted therapies, can significantly impact BCR-ABL gene expression levels, influencing test results and their interpretation.
Proper collection, storage, and timely processing of the sample are crucial. Any delays or handling errors may affect the accuracy and reliability of the results.
BCR-ABL transcript levels can vary depending on the stage of the disease-whether it is newly diagnosed, in remission, or progressing.
Results may differ based on the treatment phase. Levels typically decrease with effective therapy and are closely monitored during ongoing treatment.
Consistent testing at recommended intervals is important for accurate monitoring, trend analysis, and comparison of results over time.
A normal result means no detectable BCR-ABL transcripts or levels below the test’s detection limit. This indicates absence or very low likelihood of leukemia. In patients undergoing treatment, it suggests a good response and effective disease control.
An abnormal result means BCR-ABL transcripts are detected in the sample. This indicates the presence of leukemia or residual disease. Higher or rising levels may suggest active disease, relapse, or the need for treatment adjustment.
Reports available
Delivered via:
Choosing the right diagnostic test service near you is essential for accurate results and effective disease management. MAX@Home combines advanced molecular diagnostics with the convenience of reliable home-based services, ensuring a seamless and patient-friendly experience.
Experienced professionals ensure safe, hygienic, and minimally discomforting blood sample collection at your home.
Testing is conducted in NABL-accredited laboratories, maintaining the highest standards of quality and accuracy.
Advanced real-time PCR technology delivers precise and dependable molecular results for effective diagnosis and monitoring.
Avoid hospital visits with doorstep sample collection, designed for maximum comfort and convenience.
Backed by medical experts, MAX@Home offers reliable services with end-to-end patient support and seamless coordination.
Early detection and regular monitoring of leukaemia can significantly improve treatment outcomes. Don’t delay testing-book your BCR-ABL PCR test near me today and manage your health with confidence.
Read More
CBC (Complete Blood Count),EDTA
Cytogenetics Karyotyping-Haematologic Malignancy-(
You've selected items to compare.
View All
MAX@Home is one of Noida’s leading providers of diagnostic services, with lab-test centres located across all major localities in the city.